The Stata code written and run for the purpose of the clinical study: Measuring soluble Vascular Adhesion Protein 1 (sVAP-1) as a potential biomarker for predicting pregnancy complications.
The aim was to correlate VAP-1 serum levels (prospectively generated) with patients' characteristics and pregnancy outcomes (retrospectively collected)